Result of GM and completion of Capital Raising.


    28 July 2025 10:50:22
  • Source: Sharecast
RNS Number : 8107S
Thruvision Group PLC
28 July 2025
 





28 July 2025

Thruvision Group plc

 

Result of General Meeting and completion of Capital Raising

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology (the "Company" and, together with its subsidiary undertakings, the "Group"), announces that following the General Meeting ("GM") held earlier today, all Resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

 


Resolution

Total votes for

%

Total votes against

%

Total votes cast

Votes withheld

1.    

Authority for Directors to allot equity securities

107,552,733

99.99

10,040

0.01

107,562,773

93,085

2.    

Authority for Directors to allot equity securities for cash on a non-pre-emptive basis

107,370,131

99.82

192,642

0.18

107,562,773

93,085

 

Notes

1.     Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2.     A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

3.     All percentages have been rounded to two decimal places.

 

Completion of Capital Raising

 

Following the passing of the Resolutions at the GM, the Placing and the Retail Offer, details of which were set out in the Company's announcement on 4 July 2025 (the "Capital Raising Announcement") are expected to complete, conditional on Admission (as defined below), at 8.00 a.m. on 30 July 2025.

 

Update on audit and completion of Proposed Subscription

 

The Company is progressing its audit for the financial year ended 31 March 2025 ("FY25"). The audit process was temporarily paused whilst the strategic review was being conducted by the Board. Following the announcement of the Capital Raising, work on the audit recommenced and is progressing well, however the Company will not be in a position to publish its Preliminary Results for FY25 before 19 September 2025. As a result, the Company is not currently in a closed period pursuant to the Market Abuse Regulation EU (No 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 and is therefore able to proceed now with the Proposed Subscription on the terms anticipated in the Capital Raising Announcement (save for in respect of timings).

 

The Directors and certain employees of the Company have conditionally subscribed for a total of £375,340 (before expenses) of new Ordinary Shares pursuant to the Proposed Subscription (now, the "Subscription"). The Subscription will result in the issue and allotment of a total of 37,534,000 new Ordinary Shares (the "Subscription Shares") and is being carried out at the same issue price of 1 penny and substantially identical terms as those of the Placing. Details of the number of Subscription Shares being subscribed for and the resultant holdings of the Directors are set out below.

 

Director

Existing beneficial shareholding

New Ordinary Shares to be subscribed for

Shareholding on completion of the Capital Raising

Shareholding as a percentage of the enlarged issued share capital

Tom Black

13,272,540

20,000,000

33,272,540

7.42%

Victoria Balchin

90,804

10,000,0001

10,090,804

2.25%

Katrina Nurse

134,000

134,0001

268,000

0.06%

Richard Amos

450,000

650,0001

1,100,000

0.25%

Total

13,947,344

30,784,000

44,731,344

9.97%

 

Notes:
1 Includes Ordinary Shares subscribed for by family members as detailed in the PDMR disclosure table below

 

Related party transaction

 

The participation of the Directors in the Subscription constitutes a related party transaction for the purposes of Rule 13 of the AIM Rules for Companies. Allenby Capital Limited, the Company's nominated adviser, considers the terms of the Directors' participation in the Subscription to be fair and reasonable insofar as Shareholders are concerned.

 

Admission and Total Voting Rights

 

In total, 275,000,000 new Ordinary Shares have been issued pursuant to the Placing, Retail Offer and Subscription (the "New Ordinary Shares").

 

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and dealings in the 275,000,000 New Ordinary Shares will commence at 8.00 a.m. on 30 July 2025 and they will rank pari passu with the existing Ordinary Shares.

 

Following Admission, the enlarged share capital of the Company will consist of 448,559,010 Ordinary Shares, none of which are held in treasury. Therefore, the total number of voting rights in the Company will be 448,559,010 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

 

This announcement should be read in conjunction with the full text of the Capital Raising Announcement. Unless otherwise defined, definitions contained in this announcement have the same meaning as set out in the Capital Raising Announcement.

 

For further information please contact:

 

Thruvision Group plc                                    

Tom Black, Executive Chairman

Victoria Balchin, Chief Executive Officer

+44 (0)1235 425400



Allenby Capital Limited (NOMAD & Broker)

James Reeve / Piers Shimwell (Corporate Finance)

Jos Pinnington / Amrit Nahal (Sales)

+44 (0)20 3328 5656

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated  

a)

 

Names 

1.    Tom Black (Chairman)

2.    Victoria Balchin (CEO and CFO)

3.    John Balchin (PCA with Victoria Balchin)

4.    Daniel Balchin (PCA with Victoria Balchin)

5.    Scarlett Balchin (PCA with Victoria Balchin)

6.    Katrina Nurse (NED)

7.    Mark Nurse (PCA with Katrina Nurse)

8.    Brigid Amos (PCA with Richard Amos, NED)

2

 

Reason for the notification

a)

 

Position/status

 

As above

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Thruvision Group plc

b)

 

LEI

213800IZG9GM6G2TZE04

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of £0.01 each

b)

Identification code 

 

GB00B627R876

c)

 

Nature of the transaction 

 

Subscription for Ordinary Shares

d)

 

Price(s) and volume(s)

 



No. Shares

Price

1.

20,000,000

1p

2.

4,650,000

1p

3.

4,650,000

1p

4.

500,000

1p

5.

200,000

1p

6.

67,000

1p

7.

67,000

1p

8.

650,000

1p

 

 

d)

 

Aggregated information 

- Aggregated volume

- Price

N/A

e)

 

Date of the transactions 

28 July 2025 to be completed on 30 July 2025

f)

 

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMGCGDRISDDGUI

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.